References
- Nutt DJ. Tolerability and safety aspects of Mirtazapine. Hum Psychopharmacol 2002; 17(suppl 1)S37–41, [PUBMED], [INFOTRIEVE], [CSA]
- Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of Mirtazapine. CNS Drug Rev 2001; 7(3)249–264, [PUBMED], [INFOTRIEVE], [CSA]
- Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of Mirtazapine for the treatment of patients with major depression. J Affect Disord 1998; 51(3)267–285, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Montgomery SA. Safety of Mirtazapine: a review. Int Clin Psychopharmacol 1995; 10(Suppl 4)37–45, (Erratum in Int Clin Psychopharmacol 1996; 11(2):153)[PUBMED], [INFOTRIEVE], [CSA]
- Valazquez C, Carlson A, Stokes KA, Leikin JB. Relative safety of Mirtazapine overdose. Vet Hum Toxicol 2001; 43(6)342–344, [CSA]
- Retz W, Maier S, Maris F, Rosler M. Non-fatal Mirtazapine overdose. Int Clin Psychopharmacol 1998; 13(6)277–279, [PUBMED], [INFOTRIEVE], [CSA]
- Holzbach R, Jahn H, Pajonk FG, Mahne C. Suicide attempts with Mirtazapine overdose without complications. Biol Psychiatry 1998; 44(9)925–926, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]